Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Viemed Healthcare Inc VMD

Viemed Healthcare, Inc. through its subsidiaries, is a provider of home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The Company’s service offerings are focused on effective in-home treatment with clinical practitioners providing therapy and counselling to patients in their homes using cutting edge technologies. The Company’s products and services include Home Medical Equipment, In-home sleep testing, and Healthcare staffing. Home Medical Equipment provides respiratory and other home medical equipment, including home ventilation, bi-level positive airway pressure (BiPAP) and continuous positive airway pressure (CPAP) devices, percussion vests, and other medical equipment. In-home sleep testing provides in home sleep apnea testing services. Healthcare staffing provides healthcare staffing and recruitment services. The Company provides home medical equipment services through its interest in East Alabama HomeMed, LLC (HomeMed).


NDAQ:VMD - Post by User

Post by besttobeon Mar 18, 2022 12:38pm
113 Views
Post# 34525713

HME article CHIP shortage

HME article CHIP shortage

CQRC WARNS OF POSSIBLE ACCESS ISSUES

WASHINGTON – Patient access to in-home respiratory care may be negatively impacted if a shortage in semiconductor chips is not addressed, warns the Council for Council for Quality Respiratory Care. 

In a March 15 letter to Health and Human Services Secretary Xavier Becerra and U.S. Department of Commerce Secretary Gina Raimondo, CQRC and nine other respiratory care stakeholders urge the administration to use its authority to help address the shortage of semiconductor chips used in home respiratory care equipment. 

 “We ask that the departments prioritize allocating chips to manufacturers of home respiratory devices and ensure that medical device manufacturers receive sufficient chips to meet the medical needs of patients who rely on these devices,” the letter states. “The administration has rightly prioritized expanding access to home medical treatments, but the chip shortage places this expansion at risk.” 

In addition to CQRC, the letter was also signed by AAHomecare, Alpha 1 Foundation, American Association for Respiratory Care, COPD Foundation, Dorney-Koppel Foundation, Pulmonary Fibrosis Foundation, Respiratory Health Association, U.S. COPD Coalition and VGM & Associates. 


<< Previous
Bullboard Posts
Next >>